Deep tech describes ventures where core value comes from novel science or engineering — not primarily from go-to-market execution on commoditized software.

How it works

Categories include advanced semiconductors, quantum, synthetic biology, robotics, energy storage, and aerospace systems. These companies often spin out of university labs or national research programs.

Capital intensity is high: specialized equipment, regulated trials, and long iteration loops before revenue. Milestones read as proof-of-concept, pilot manufacturing, regulatory clearance — not just MRR growth.

Moats stem from patents, trade secrets, and team expertise that is hard to replicate quickly. Go-to-market may partner with incumbents who manufacture or distribute, slowing direct sales cycles.

Investors include dedicated deep-tech funds, corporate strategics, and government grants. Dilution paths can include non-dilutive SBIR or defense contracts alongside venture rounds.

Due diligence pulls in technical experts who stress-test whether lab results scale commercially.

Why it matters

• Founders: Align investor expectations on timeline and failure modes. Show capital-efficient milestones — derisk the science before scaling headcount.
• Investors: Portfolio construction needs longer fund lives or reserve strategies. A SaaS pacing model misprices deep-tech option value and capital calls.

Common mistake

Pitching deep tech with SaaS metrics alone before technical de-risking. Without credible prototypes or IP, TAM slides do not close rounds.

Related ideas

See also defense tech, capex-heavy, hard tech, and technology readiness level (TRL).